ArticleBritish journal of haematology2022

Idelalisib reduces regulatory T cells and activates T helper 17 cell differentiation in relapsed refractory patients with chronic lymphocytic leukaemia.

Deepti Gadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.